Testing effectiveness (Phase 2)Study completedNCT03416153
What this trial is testing
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
Who this might be right for
Oropharynx Cancer
University of Michigan Rogel Cancer Center 91